China Meheco Group (600056.SH): Injection of Isavuconazole Sulfate obtained drug registration certificate.

16:25 17/03/2026

China Pharmaceutical (stock code: 600056.SH) announced recently that its wholly-owned subsidiary, Hainan Tongyong Sanyang Pharmaceutical Co., Ltd. (referred to as "Sanyang Pharmaceutical"), has received the "Drug Registration Certificate" for injection of Isavuconazole approved and issued by the National Medical Products Administration (referred to as "NMPA").

China Meheco Group (600056.SH) announced that its wholly-owned subsidiary, Hainan Tongyong Sanyang Pharmaceutical Co., Ltd. (hereinafter referred to as "Sanyang Pharmaceutical"), recently received the "Drug Registration Certificate" for injection use of Isavuconazole approved and issued by the National Medical Products Administration (hereinafter referred to as "NMPA"). Obtaining this drug registration certificate will help enrich the company's product line and accumulate valuable experience for the company's subsequent development of generic drugs.

XD INC (02400) spent approximately HK$7.9111 million to repurchase 108,000 shares on March 17th.

AV Concept Holdings spent HK$120,000 to repurchase 300,000 shares on March 17th.

YURUN FOOD(01068) issues profit warning, expecting a loss of approximately HK$70 million for the year 2025, compared to the previous year.

XD INC (02400) spent approximately HK$7.9111 million to repurchase 108,000 shares on March 17th.

AV Concept Holdings spent HK$120,000 to repurchase 300,000 shares on March 17th.

YURUN FOOD(01068) issues profit warning, expecting a loss of approximately HK$70 million for the year 2025, compared to the previous year.